# Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload

> **NCT01039636** · PHASE1 · COMPLETED · sponsor: **FerroKin BioSciences, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Transfusional Iron Overload
- Beta-thalassemia

## Interventions

- **DRUG:** FBS0701

## Key facts

- **NCT ID:** NCT01039636
- **Lead sponsor:** FerroKin BioSciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-12
- **Final completion:** —
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01039636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01039636, "Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01039636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*